Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis

NCT04188301 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04188301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04188301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Completed
Start date
December 6, 2019
Completion date
June 1, 2022
Enrollment
154 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

onchocerciasis